Abstract:The misfolding and aggregation of β-amyloid peptides (Aβ) into amyloid fibrils, a process that has been pathologically linked to the onset of Alzheimer's disease, is dependent on the presence of a heterogeneous surface (e.g., cell membrane). Understanding of the kinetics of amyloid fibril formation and associated structural transition from monomers to intermediates and eventually to fibrils is critical for the development of viable therapeutic agents. In this work, using circular dichroism (CD), atomic force microscopy (AFM), surface plasmon resonance (SPR), and molecular dynamics (MD) simulations, we studied the adsorption, aggregation, and conformational changes of Aβ(1-42) from fresh monomers to fully grown fibrils on four model self-assembled monolayers (SAMs): hydrophobic CH(3)-terminated SAM, hydrophilic OH-terminated SAM, negatively charged COOH-terminated SAMs, and positively charged NH(2)-terminated SAM. The seeding effect of Aβ(1-42) on the kinetics of Aβ aggregation on different SAMs is also examined. The CD, AFM, and SPR data show that all of these SAMs greatly accelerate the formation of β-sheets and amyloid fibrils through surface-enhanced interactions, but Aβ(1-42) peptides preferentially adsorb on a hydrophobic CH(3)-SAM and a positively charged NH(2)-SAM with much stronger interactions than on a hydrophilic OH-SAM and a negatively charged COOH-SAM. MD simulations further reveal that hydrophobic interactions present a general driving force for Aβ adsorption on all SAMs. As Aβ aggregates grow into larger species by packing hydrophobic C-terminals to form a hydrophobic core while exposing hydrophilic and negatively charged N-terminals to solution, electrostatic interactions become more strengthened when they interact with the SAMs especially for the COOH-SAM and the NH(2)-SAM. Thus, both hydrophobic and electrostatic interactions contribute differently to different Aβ-SAM systems and to different aggregation stages. A postulated mechanism is proposed to describe the structure and kinetics of Aβ aggregation from aqueous solution to the SAMs, providing valuable insights into Aβ aggregation on biological cell membranes.

Physical Mechanism of Amyloid-β Peptide Chain Aggregation on Fluidic Lipid Nanotubules

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The low frequency reflection characteristics of the fundamental antisymmetric Lamb wave a0 from a rectangular notch in a plate.

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.

Aggregation mechanisms and molecular structures of amyloid‐β in Alzheimer's disease

Membrane-assisted Aβ40 aggregation pathways

Aggregation Behavior of Amyloid Beta Peptide Depends Upon the Membrane Lipid Composition

Location and conformation of amyloid β(25-35) peptide and its sequence-shuffled peptides within membranes: implications for aggregation and toxicity in PC12 cells.

Aggregation of the amyloid-β peptide (Aβ40) within condensates generated through liquid–liquid phase separation

Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication

Amyloid Fibril Formation on Neuronal Cells in the Coexistence of Aβ40 and Aβ42

Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein

The Influence of Lipid Electric Charge on the Binding of Aβ(1–42) Amyloid Peptide to Bilayers in the Liquid-Ordered State

Amyloid-β Peptide Aggregation and the Influence of Carbon Nanoparticles

CAPS Facilitates Filling of the Rapidly Releasable Pool of Large Dense-Core Vesicles

Nanopore analysis of β-amyloid peptide aggregation transition induced by small molecules.

Investigation of the Aggregation Process of Amyloid-Β-(16-22) Peptides and the Dissolution of Intermediate Aggregates.

Modulation of Lipid Dynamics in the β-Amyloid Aggregates Induced Membrane Fragmentation

Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series.

Membrane Binding and Pore Formation by a Cytotoxic Fragment of Amyloid β Peptide.